# Phreesia, Inc. (PHR) · Edgar & Edgarette company card

> Phreesia (PHR) grew revenue 14.5% in FY2026 to $481 million, operating margin -1.4% against a 7.9% median for business services, equity 50.8% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1412408 · fiscal year ended 2026-01-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/PHR) · [JSON](https://www.pops4.com/boards/company/PHR.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $481M |
| Revenue growth, 1 year | 14.5% |
| Revenue growth per year | 22.5% |
| Operating margin | -1.4% (prior year -13.8%) |
| Net margin | 0.5% |
| Operating cash flow | $79M |
| Capital spending | $11M |
| Free cash flow | $68M |
| Cash | $74M |
| Long-term debt | $100M |
| Total assets | $664M |
| Total equity | $337M |
| Equity ÷ assets | 50.8% |
| Return on equity | 0.7% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -1.95 (distress zone)
- Piotroski F: 5 of 9 (middling)
- Health Harbor boat: Sound ship · one warning sign · operating loss: a margin of -1.4% in FY2026
- Cash Compass: Cash cow later · growing fast, and already turning revenue into cash

## Edgarette's reading

Exposure: revenue $480.6M (FY2026), total debt $100.1M. Experience: revenue up 14.5% on the year, up 22.5% a year over 4 years; operating margin -1.4%, up from -13.8%. Soundness: equity 50.8% of assets, return on equity 0.7%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $471.5M and $644.8M next year (method v4.1: its own 5-year record of growth weighed at 57% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $435.7M to $700.1M. A statistical range, not company guidance. Against peers (70 filers, $50M+ revenue, services-business services, nec): operating margin -1.4% against a 7.9% median; growth 14.5% against 10.2%.

Range logged 2026-09-29, receipt 9c7313e0babe8a2e, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 1, latest 2026-02-23 ([filing](https://www.sec.gov/Archives/edgar/data/1412408/000141240826000054/0001412408-26-000054-index.htm))

## Recent filings

- 10-Q · filed 2026-09-03 · [filing](https://www.sec.gov/Archives/edgar/data/1412408/000141240826000223/0001412408-26-000223-index.htm)
- 8-K · filed 2026-09-02 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1412408/000141240826000213/0001412408-26-000213-index.htm)
- 8-K · filed 2026-06-24 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/1412408/000141240826000176/0001412408-26-000176-index.htm)
- 10-Q · filed 2026-05-28 · [filing](https://www.sec.gov/Archives/edgar/data/1412408/000141240826000172/0001412408-26-000172-index.htm)
- 8-K · filed 2026-05-27 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1412408/000141240826000166/0001412408-26-000166-index.htm)
- DEF 14A · filed 2026-05-14 · [filing](https://www.sec.gov/Archives/edgar/data/1412408/000141240826000155/0001412408-26-000155-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001412408.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1412408

## Cite

POPS4, Edgar & Edgarette: Phreesia, Inc. (PHR) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/PHR. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.